TYR-97835-59752
3 vaccinations
5 coded responses
11 check-ins
5 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 906 / CA
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-23
Registered in v-safe
-
2020-12-23
Dose 1 — Pfizer-BioNTech
- 2020-12-23
-
2020-12-25
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-01-01
Survey response — day 7, dose 1MedDRA: Ageusia, Anosmia, COVID-19 — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Systemic reaction (other): Loss of taste and smell · Healthcare visit (other): Diagnosed with COVID on 12/31/20MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-01
Report sent to call center — day 7, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-06
Survey response — day 14, dose 1MedDRA: Ageusia, Anosmia, Chest pain, Dyspnoea, Nasal congestion — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Loss of tasteLoss of smellExtreme nasal congestionOccasional chest pain and shortness of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-06
Report sent to call center — day 14, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-21
Dose 2 — Pfizer-BioNTech
-
2021-01-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-23
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-24
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-01-26
-
2021-02-04
Survey response — day 14, dose 2MedDRA: Headache, Nausea — Feeling: Poor · Be unable to work, Be unable to do your normal daily activitiesFree text: HeadachesNauseaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-18
Survey response — day 28, dose 2MedDRA: Dizziness, Fatigue, Headache, Pain — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Really bad headachesDizzinessFatigueBody achesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-18
Report sent to call center — day 28, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-07-22
Survey response — 6 months, dose 2MedDRA: Back pain, Myalgia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Muscular pain in back and stomachMedDRA releases: 2024-11 · check-in free text available
-
2021-07-22
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-23
-
2021-10-04
Dose 3 — Pfizer-BioNTech
- 2022-01-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-21 | Pfizer-BioNTech | |
| 3 | 2021-10-04 | Pfizer-BioNTech | No |
Call center
4 call center cases
4 unsuccessful
Free text
Release 1 — day 7, dose 1
Systemic reaction (other): Loss of taste and smell
Healthcare visit (other): Diagnosed with COVID on 12/31/20
Release 1 — day 14, dose 1
Symptoms: Loss of tasteLoss of smellExtreme nasal congestionOccasional chest pain and shortness of breath
Release 3 — day 14, dose 2
Symptoms: HeadachesNausea
Release 4 — day 28, dose 2
Symptoms: Really bad headachesDizzinessFatigueBody aches
Release 9 — 6 months, dose 2
Symptoms: Muscular pain in back and stomach
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | COVID-19 | ✓ | ✓ | ✓ |
| SD | Ageusia | ✓ | ✓ | ✓ |
| SD | Anosmia | ✓ | ✓ | ✓ |
| SD | Back pain | · | · | ✓ |
| SD | Chest pain | ✓ | ✓ | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SRO | Ageusia | ✓ | ✓ | ✓ |
| SRO | Anosmia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release